Betty Smoot1, Kord M Kober, Steven M Paul, Jon D Levine, Gary Abrams, Judy Mastick, Kimberly Topp, Yvette P Conley, Christine A Miaskowski. 1. Betty Smoot, PT, DPTSc, MAS, is Associate Professor, School of Medicine, University of California San Francisco. Kord M. Kober, PhD, is Assistant Professor; and Steven M. Paul, PhD, is Principal Statistician, School of Nursing, University of California San Francisco. Jon D. Levine, MD, is Professor; and Gary Abrams, MD, is Professor, School of Medicine, University of California San Francisco. Judy Mastick, RN, MN, is Project Director, School of Nursing, University of California San Francisco. Kimberly Topp, PT, PhD, is Professor, School of Medicine, University of California San Francisco. Yvette P. Conley, PhD, FAAN, is Professor, School of Nursing, University of Pittsburgh, Pennsylvania. Christine Miaskowski, PhD, RN, FAAN, is Professor, School of Nursing, University of California San Francisco.
Abstract
BACKGROUND: Potassium (K) channels play an important role in lymph pump activity, lymph formation, lymph transport, and the functions of lymph nodes. No studies have examined the relationship between K channel candidate genes and the development of secondary lymphedema (LE). OBJECTIVE: The study purpose was to evaluate for differences in genotypic characteristics in women who did (n = 155) or did not (n = 387) develop upper extremity LE following breast cancer treatment based on an analysis of single-nucleotide polymorphisms (SNPs) and haplotypes in 10 K channel genes. METHODS: Upper extremity LE was diagnosed using bioimpedance resistance ratios. Logistic regression analyses were used to identify those SNPs and haplotypes that were associated with LE while controlling for relevant demographic, clinical, and genomic characteristics. RESULTS: Patients with LE had a higher body mass index, had a higher number of lymph nodes removed, had more advanced disease, received adjuvant chemotherapy, received radiation therapy, and were less likely to have undergone a sentinel lymph node biopsy. One SNP in a voltage-gated K channel gene (KCNA1 rs4766311), four in two inward-rectifying K channel genes (KCNJ3 rs1037091 and KCNJ6 rs2211845, rs991985, rs2836019), and one in a two-pore K channel gene (KCNK3 rs1662988) were associated with LE. DISCUSSION: These preliminary findings suggest that K channel genes play a role in the development of secondary LE.
BACKGROUND: Potassium (K) channels play an important role in lymph pump activity, lymph formation, lymph transport, and the functions of lymph nodes. No studies have examined the relationship between K channel candidate genes and the development of secondary lymphedema (LE). OBJECTIVE: The study purpose was to evaluate for differences in genotypic characteristics in women who did (n = 155) or did not (n = 387) develop upper extremity LE following breast cancer treatment based on an analysis of single-nucleotide polymorphisms (SNPs) and haplotypes in 10 K channel genes. METHODS: Upper extremity LE was diagnosed using bioimpedance resistance ratios. Logistic regression analyses were used to identify those SNPs and haplotypes that were associated with LE while controlling for relevant demographic, clinical, and genomic characteristics. RESULTS:Patients with LE had a higher body mass index, had a higher number of lymph nodes removed, had more advanced disease, received adjuvant chemotherapy, received radiation therapy, and were less likely to have undergone a sentinel lymph node biopsy. One SNP in a voltage-gated K channel gene (KCNA1rs4766311), four in two inward-rectifying K channel genes (KCNJ3rs1037091 and KCNJ6rs2211845, rs991985, rs2836019), and one in a two-pore K channel gene (KCNK3rs1662988) were associated with LE. DISCUSSION: These preliminary findings suggest that K channel genes play a role in the development of secondary LE.
Authors: Clive J Hoggart; Eteban J Parra; Mark D Shriver; Carolina Bonilla; Rick A Kittles; David G Clayton; Paul M McKeigue Journal: Am J Hum Genet Date: 2003-06 Impact factor: 11.025
Authors: Pierre-Yves von der Weid; Sonia Rehal; Peter Dyrda; Stewart Lee; Ryan Mathias; Mozibur Rahman; Simon Roizes; Mohammad S Imtiaz Journal: J Physiol Date: 2012-03-25 Impact factor: 5.182
Authors: Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich Journal: Nat Genet Date: 2006-07-23 Impact factor: 38.330
Authors: José Luiz B Bevilacqua; Michael W Kattan; Yu Changhong; Sergio Koifman; Inês E Mattos; Rosalina J Koifman; Anke Bergmann Journal: Ann Surg Oncol Date: 2012-03-07 Impact factor: 5.344
Authors: Dale J Langford; Claudia West; Charles Elboim; Bruce A Cooper; Gary Abrams; Steven M Paul; Brian L Schmidt; Jon D Levine; John D Merriman; Anand Dhruva; John Neuhaus; Heather Leutwyler; Christina Baggott; Carmen Ward Sullivan; Bradley E Aouizerat; Christine Miaskowski Journal: J Neurogenet Date: 2014-01-07 Impact factor: 1.250
Authors: Donna Karolchik; Galt P Barber; Jonathan Casper; Hiram Clawson; Melissa S Cline; Mark Diekhans; Timothy R Dreszer; Pauline A Fujita; Luvina Guruvadoo; Maximilian Haeussler; Rachel A Harte; Steve Heitner; Angie S Hinrichs; Katrina Learned; Brian T Lee; Chin H Li; Brian J Raney; Brooke Rhead; Kate R Rosenbloom; Cricket A Sloan; Matthew L Speir; Ann S Zweig; David Haussler; Robert M Kuhn; W James Kent Journal: Nucleic Acids Res Date: 2013-11-21 Impact factor: 16.971
Authors: Michael Bernas; Saskia R J Thiadens; Betty Smoot; Jane M Armer; Paula Stewart; Jay Granzow Journal: Clin Exp Metastasis Date: 2018-05-17 Impact factor: 5.150
Authors: Mei R Fu; Bradley E Aouizerat; Gary Yu; Yvette Conley; Deborah Axelrod; Amber A Guth; Jean-Pierre Gagner; Jeanna M Qiu; David Zagzag Journal: Curr Breast Cancer Rep Date: 2020-11-24